Literature DB >> 30025986

Topical insulin in neurotrophic keratopathy after resection of acoustic neuroma.

V Galvis1, C A Niño2, A Tello3, J M Grice4, M A Gómez4.   

Abstract

CASE REPORT: A patient with a history of surgical resection of an acoustic neuroma presented with involvement of both the left facial nerve and the left trigeminal nerve. She initially consulted for exposure keratitis, but two weeks later presented with an infectious keratitis. After taking the corneal sample, she presented with persistent epithelial defect, which did not respond to medical management. Topical insulin was indicated, and a decrease in the area of the lesion was seen in the following 5 days. A therapeutic contact lens was also placed at that time and finally, two weeks after the initiation of insulin, the epithelial defect completely closed. DISCUSSION: This was a complex case due to the confluence of facial paralysis, neurotrophic keratitis, and infectious keratitis, which finally had a successful outcome. Topical insulin can be an effective adjuvant therapy in cases of neurotrophic ulcers that do not respond to standard therapy.
Copyright © 2018 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Corneal ulcer; Facial nerve; Insulin; Insulina; Keratitis; Nervio facial; Nervio trigémino; Queratitis; Schwannoma; Trigeminal nerve; Úlcera de la córnea

Mesh:

Substances:

Year:  2018        PMID: 30025986     DOI: 10.1016/j.oftal.2018.06.003

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol (Engl Ed)        ISSN: 2173-5794


  5 in total

1.  Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF.

Authors:  Alessandro Meduri; Giovanni William Oliverio; Antonio Valastro; Claudia Azzaro; Umberto Camellin; Francesco Franchina; Leandro Inferrera; Anna Roszkowska; Pasquale Aragona
Journal:  Front Med (Lausanne)       Date:  2022-05-30

2.  Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases.

Authors:  Ronald M Sánchez-Ávila; Edmar Uribe-Badillo; Carlos Fernández-Vega González; Francisco Muruzabal; Borja de la Sen-Corcuera; Begoña Baamonde; Luis M Quirós; Eduardo Anitua; Jesús Merayo-Lloves
Journal:  Vision (Basel)       Date:  2021-07-02

3.  Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.

Authors:  Bennie H Jeng; Pedram Hamrah; Ziv Z Kirshner; Benjamin C Mendez; Howard C Wessel; Larry R Brown; David L Steed
Journal:  Transl Vis Sci Technol       Date:  2022-01-03       Impact factor: 3.283

Review 4.  Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets.

Authors:  Deanna H Dang; Kamran M Riaz; Dimitrios Karamichos
Journal:  Drugs       Date:  2022-01-13       Impact factor: 9.546

5.  Using Convolutional Neural Network as a Statistical Algorithm to Explore the Therapeutic Effect of Insulin Liposomes on Corneal Inflammation.

Authors:  Yukun Liao; Huiting Jiang; Yangrui Du; Xiaojing Xiong; Yu Zhang; Zhiyu Du
Journal:  Comput Intell Neurosci       Date:  2022-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.